Cargando…

Effects of anti-PD-1 immunotherapy on tumor regression: insights from a patient-derived xenograft model

Immunotherapies, such as checkpoint blockade of programmed cell death protein-1 (PD-1), have resulted in unprecedented improvements in survival for patients with lung cancer. Nonetheless, not all patients benefit equally and many issues remain unresolved, including the mechanisms of action and the p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Martín-Ruiz, Asunción, Fiuza-Luces, Carmen, Martínez-Martínez, Esther, Arias, Clemente F., Gutiérrez, Lourdes, Ramírez, Manuel, Martín-Acosta, Paloma, Coronado, Maria José, Lucia, Alejandro, Provencio, Mariano
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7184589/ https://www.ncbi.nlm.nih.gov/pubmed/32341383 http://dx.doi.org/10.1038/s41598-020-63796-w

Ejemplares similares

CB(2) cannabinoid receptor activation promotes colon cancer progression via AKT/GSK3β signaling pathway
por: Martínez-Martínez, Esther, et al.
Publicado: (2016)

Concordance between circulating tumor cells and clinical status during follow-up in anaplastic lymphoma kinase (ALK) non-small-cell lung cancer patients
por: Provencio, Mariano, et al.
Publicado: (2017)

Exercise and quality of life in cancer
por: Fiuza-Luces, Carmen, et al.
Publicado: (2023)

PGC-1alpha levels correlate with survival in patients with stage III NSCLC and may define a new biomarker to metabolism-targeted therapy
por: Cruz-Bermúdez, Alberto, et al.
Publicado: (2017)

The Second Wind in McArdle Patients: Fitness Matters
por: Salazar-Martínez, Eduardo, et al.
Publicado: (2021)

The Era of Smartphones: Back to Our Biological Makeup?
por: Santos-Lozano, Alejandro, et al.
Publicado: (2016)

Cannabinoids receptor type 2, CB(2), expression correlates with human colon cancer progression and predicts patient survival
por: Martínez-Martínez, Esther, et al.
Publicado: (2015)

Characterization of immune responses to anti-PD-1 mono and combination immunotherapy in hematopoietic humanized mice implanted with tumor xenografts
por: Capasso, A., et al.
Publicado: (2019)

Pathophysiology of Cerebellar Degeneration in Mitochondrial Disorders: Insights from the Harlequin Mouse
por: Fernández de la Torre, Miguel, et al.
Publicado: (2023)

The Role of Metabolism in Tumor Immune Evasion: Novel Approaches to Improve Immunotherapy
por: Cruz-Bermúdez, Alberto, et al.
Publicado: (2021)

Protocol to generate a patient derived xenograft model of acquired resistance to immunotherapy in humanized mice
por: Martínez-Sabadell, Alex, et al.
Publicado: (2022)

Apoptosis-Inducing Factor Deficiency Induces Tissue-Specific Alterations in Autophagy: Insights from a Preclinical Model of Mitochondrial Disease and Exercise Training Effects
por: Laine-Menéndez, Sara, et al.
Publicado: (2022)

An HPV-E6/E7 immunotherapy plus PD-1 checkpoint inhibition results in tumor regression and reduction in PD-L1 expression
por: Rice, Adrian E, et al.
Publicado: (2015)

Exercise and Childhood Cancer—A Historical Review
por: Morales, Javier S., et al.
Publicado: (2021)

Immunohistochemical and Molecular Characteristics with Prognostic Significance in Diffuse Large B-Cell Lymphoma
por: Bellas, Carmen, et al.
Publicado: (2014)

Exercise Training and Natural Killer Cells in Cancer Survivors: Current Evidence and Research Gaps Based on a Systematic Review and Meta-analysis
por: Valenzuela, Pedro L., et al.
Publicado: (2022)

Exercise Training and Neurodegeneration in Mitochondrial Disorders: Insights From the Harlequin Mouse
por: Fernández-de la Torre, Miguel, et al.
Publicado: (2020)

Programmed Death-Ligand 1 (PD-L1) as Immunotherapy Biomarker in Breast Cancer
por: Núñez Abad, Martín, et al.
Publicado: (2022)

The Phytosterol Peniocerol Inhibits Cell Proliferation and Tumor Growth in a Colon Cancer Xenograft Model
por: Couder-García, Beatriz del Carmen, et al.
Publicado: (2019)

Spontaneous regression of human acute myeloid leukaemia xenografts and phenotypic evidence for maturation.
por: Palú, G., et al.
Publicado: (1979)

The addition of abemaciclib to sunitinib induces regression of renal cell carcinoma xenograft tumors
por: Small, Jeffrey, et al.
Publicado: (2017)

Immunotherapy Moves to the Early-Stage Setting in Non-Small Cell Lung Cancer: Emerging Evidence and the Role of Biomarkers
por: Mielgo-Rubio, Xabier, et al.
Publicado: (2020)

HLA Allele E*01:01 Is Associated with a Reduced Risk of EBV-Related Classical Hodgkin Lymphoma Independently of HLA-A*01/*02
por: Martín, Paloma, et al.
Publicado: (2015)

Tailored Exercise during Hematopoietic Stem Cell Transplantation Hospitalization in Children with Cancer: A Prospective Cohort Study
por: Morales, Javier S., et al.
Publicado: (2020)

Next-generation sequencing to dynamically detect mechanisms of resistance to ALK inhibitors in ALK-positive NSCLC patients: a case report
por: Sánchez-Herrero, Estela, et al.
Publicado: (2020)

An update on immunotherapy with PD-1 and PD-L1 blockade
por: Koh, Sung Ae
Publicado: (2021)

Masticadienonic and 3α-OH Masticadienoic Acids Induce Apoptosis and Inhibit Cell Proliferation and Tumor Growth in Prostate Cancer Xenografts In Vivo
por: Sánchez-Monroy, Ma. Beatriz, et al.
Publicado: (2017)

Natural killer T cell immunotherapy combined with IL-15-expressing oncolytic virotherapy and PD-1 blockade mediates pancreatic tumor regression
por: Nelson, Adam, et al.
Publicado: (2022)

The K153R Polymorphism in the Myostatin Gene and Muscle Power Phenotypes in Young, Non-Athletic Men
por: Santiago, Catalina, et al.
Publicado: (2011)

Regulatory cells and the effect of cancer immunotherapy
por: Iglesias-Escudero, María, et al.
Publicado: (2023)

Physical Exercise and Mitochondrial Disease: Insights From a Mouse Model
por: Fiuza-Luces, Carmen, et al.
Publicado: (2019)

ODP342 Panhypopituitarism Induced by CTLA-4 and PD-1/PD-L1 Inhibitor Immunotherapy
por: Hernandez-Cordero, Nicole, et al.
Publicado: (2022)

Exosomes enriched in stemness/metastatic-related mRNAS promote oncogenic potential in breast cancer
por: Rodríguez, Marta, et al.
Publicado: (2015)

Targeting PD-1/PD-L1 interactions for cancer immunotherapy
por: Zitvogel, Laurence, et al.
Publicado: (2012)

Human Cancer Immunotherapy with PD-1/PD-L1 Blockade
por: Zheng, Peilin, et al.
Publicado: (2015)

PD-1/PD-L1 Checkpoint Inhibitors in Tumor Immunotherapy
por: Liu, Jinhua, et al.
Publicado: (2021)

Immunotherapies in ovarian cancer
por: García-Martínez, Elena, et al.
Publicado: (2020)

Regression Networks for Neurophysiological Indicator Evaluation in Practicing Motor Imagery Tasks
por: Velasquez-Martinez, Luisa, et al.
Publicado: (2020)

Health-related quality of life of Spanish children with cystic fibrosis
por: Groeneveld, Iris F., et al.
Publicado: (2012)

Validation and Determination of Physical Activity Intensity GT3X+ Cut-Points in Children and Adolescents with Physical Disabilities: Preliminary Results in a Cerebral Palsy Population
por: Matey-Rodríguez, Carmen, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_vtje68p9sjkc84o8d4frii7j9j